Envoy Medical, Inc.
Envoy Medical, Inc. COCH Peers
See (COCH) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| COCH | $1.65 | +3.13% | 35.19M | -1.20 | -$1.37 | N/A |
| ABT | $131.47 | -1.19% | 228.74B | 17.05 | $7.71 | +1.73% |
| BSX-PA | $122.18 | +2.37% | 175.45B | 230.53 | $0.53 | N/A |
| BSX | $104.46 | -0.17% | 154.54B | 76.25 | $1.37 | N/A |
| SYK | $378.24 | -0.40% | 144.55B | 51.04 | $7.41 | +0.86% |
| MDT | $80.92 | -4.13% | 103.78B | 22.42 | $3.61 | +3.45% |
| EW | $74.79 | -1.72% | 43.87B | 30.90 | $2.42 | N/A |
| DXCM | $84.83 | -0.07% | 33.26B | 63.78 | $1.33 | N/A |
| STE | $243.65 | -1.09% | 23.94B | 39.55 | $6.16 | +0.91% |
| PODD | $321.00 | -1.08% | 22.59B | 57.84 | $5.55 | N/A |
Stock Comparison
COCH vs ABT Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ABT has a market cap of 228.74B. Regarding current trading prices, COCH is priced at $1.65, while ABT trades at $131.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ABT's P/E ratio is 17.05. In terms of profitability, COCH's ROE is +1.06%, compared to ABT's ROE of +0.24%. Regarding short-term risk, COCH is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs BSX-PA Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, BSX-PA has a market cap of 175.45B. Regarding current trading prices, COCH is priced at $1.65, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, COCH's ROE is +1.06%, compared to BSX-PA's ROE of +0.10%. Regarding short-term risk, COCH is less volatile compared to BSX-PA. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs BSX Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, BSX has a market cap of 154.54B. Regarding current trading prices, COCH is priced at $1.65, while BSX trades at $104.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas BSX's P/E ratio is 76.25. In terms of profitability, COCH's ROE is +1.06%, compared to BSX's ROE of +0.10%. Regarding short-term risk, COCH is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs SYK Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, SYK has a market cap of 144.55B. Regarding current trading prices, COCH is priced at $1.65, while SYK trades at $378.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas SYK's P/E ratio is 51.04. In terms of profitability, COCH's ROE is +1.06%, compared to SYK's ROE of +0.11%. Regarding short-term risk, COCH is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs MDT Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, MDT has a market cap of 103.78B. Regarding current trading prices, COCH is priced at $1.65, while MDT trades at $80.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas MDT's P/E ratio is 22.42. In terms of profitability, COCH's ROE is +1.06%, compared to MDT's ROE of +0.09%. Regarding short-term risk, COCH is less volatile compared to MDT. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs EW Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, EW has a market cap of 43.87B. Regarding current trading prices, COCH is priced at $1.65, while EW trades at $74.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas EW's P/E ratio is 30.90. In terms of profitability, COCH's ROE is +1.06%, compared to EW's ROE of +0.49%. Regarding short-term risk, COCH is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs DXCM Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, DXCM has a market cap of 33.26B. Regarding current trading prices, COCH is priced at $1.65, while DXCM trades at $84.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas DXCM's P/E ratio is 63.78. In terms of profitability, COCH's ROE is +1.06%, compared to DXCM's ROE of +0.24%. Regarding short-term risk, COCH is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs STE Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, STE has a market cap of 23.94B. Regarding current trading prices, COCH is priced at $1.65, while STE trades at $243.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas STE's P/E ratio is 39.55. In terms of profitability, COCH's ROE is +1.06%, compared to STE's ROE of +0.09%. Regarding short-term risk, COCH is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs PODD Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, PODD has a market cap of 22.59B. Regarding current trading prices, COCH is priced at $1.65, while PODD trades at $321.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas PODD's P/E ratio is 57.84. In terms of profitability, COCH's ROE is +1.06%, compared to PODD's ROE of +0.35%. Regarding short-term risk, COCH is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs PHG Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, PHG has a market cap of 21.35B. Regarding current trading prices, COCH is priced at $1.65, while PHG trades at $23.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas PHG's P/E ratio is 79.59. In terms of profitability, COCH's ROE is +1.06%, compared to PHG's ROE of +0.03%. Regarding short-term risk, COCH is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs ZBH Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ZBH has a market cap of 18.13B. Regarding current trading prices, COCH is priced at $1.65, while ZBH trades at $91.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ZBH's P/E ratio is 20.37. In terms of profitability, COCH's ROE is +1.06%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, COCH is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs ABMD Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ABMD has a market cap of 17.18B. Regarding current trading prices, COCH is priced at $1.65, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ABMD's P/E ratio is 65.36. In terms of profitability, COCH's ROE is +1.06%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, COCH is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs SWAV Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, SWAV has a market cap of 12.57B. Regarding current trading prices, COCH is priced at $1.65, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas SWAV's P/E ratio is 78.76. In terms of profitability, COCH's ROE is +1.06%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, COCH is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs ALGN Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ALGN has a market cap of 12.51B. Regarding current trading prices, COCH is priced at $1.65, while ALGN trades at $172.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ALGN's P/E ratio is 31.38. In terms of profitability, COCH's ROE is +1.06%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, COCH is less volatile compared to ALGN. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs SNN Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, SNN has a market cap of 12.42B. Regarding current trading prices, COCH is priced at $1.65, while SNN trades at $28.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas SNN's P/E ratio is 30.19. In terms of profitability, COCH's ROE is +1.06%, compared to SNN's ROE of +0.08%. Regarding short-term risk, COCH is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs PEN Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, PEN has a market cap of 10.34B. Regarding current trading prices, COCH is priced at $1.65, while PEN trades at $267.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas PEN's P/E ratio is 249.56. In terms of profitability, COCH's ROE is +1.06%, compared to PEN's ROE of +0.04%. Regarding short-term risk, COCH is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs GMED Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, GMED has a market cap of 7.94B. Regarding current trading prices, COCH is priced at $1.65, while GMED trades at $58.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas GMED's P/E ratio is 43.77. In terms of profitability, COCH's ROE is +1.06%, compared to GMED's ROE of +0.05%. Regarding short-term risk, COCH is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs BIO-B Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, BIO-B has a market cap of 6.76B. Regarding current trading prices, COCH is priced at $1.65, while BIO-B trades at $250.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas BIO-B's P/E ratio is -3.83. In terms of profitability, COCH's ROE is +1.06%, compared to BIO-B's ROE of -0.32%. Regarding short-term risk, COCH is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs BIO Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, BIO has a market cap of 6.19B. Regarding current trading prices, COCH is priced at $1.65, while BIO trades at $227.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas BIO's P/E ratio is -2.97. In terms of profitability, COCH's ROE is +1.06%, compared to BIO's ROE of -0.32%. Regarding short-term risk, COCH is less volatile compared to BIO. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs GKOS Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, GKOS has a market cap of 5.56B. Regarding current trading prices, COCH is priced at $1.65, while GKOS trades at $97.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas GKOS's P/E ratio is -42.83. In terms of profitability, COCH's ROE is +1.06%, compared to GKOS's ROE of -0.17%. Regarding short-term risk, COCH is less volatile compared to GKOS. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs BRKR Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, BRKR has a market cap of 5.51B. Regarding current trading prices, COCH is priced at $1.65, while BRKR trades at $36.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas BRKR's P/E ratio is 69.88. In terms of profitability, COCH's ROE is +1.06%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, COCH is less volatile compared to BRKR. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs NARI Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, NARI has a market cap of 4.68B. Regarding current trading prices, COCH is priced at $1.65, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas NARI's P/E ratio is -59.24. In terms of profitability, COCH's ROE is +1.06%, compared to NARI's ROE of -0.18%. Regarding short-term risk, COCH is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs IRTC Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, IRTC has a market cap of 4.54B. Regarding current trading prices, COCH is priced at $1.65, while IRTC trades at $142.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas IRTC's P/E ratio is -45.45. In terms of profitability, COCH's ROE is +1.06%, compared to IRTC's ROE of -1.13%. Regarding short-term risk, COCH is less volatile compared to IRTC. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs INSP Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, INSP has a market cap of 4.30B. Regarding current trading prices, COCH is priced at $1.65, while INSP trades at $145.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas INSP's P/E ratio is 66.60. In terms of profitability, COCH's ROE is +1.06%, compared to INSP's ROE of +0.10%. Regarding short-term risk, COCH is less volatile compared to INSP. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs TMDX Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, TMDX has a market cap of 4.17B. Regarding current trading prices, COCH is priced at $1.65, while TMDX trades at $123.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas TMDX's P/E ratio is 86.86. In terms of profitability, COCH's ROE is +1.06%, compared to TMDX's ROE of +0.22%. Regarding short-term risk, COCH is less volatile compared to TMDX. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs ITGR Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ITGR has a market cap of 4.12B. Regarding current trading prices, COCH is priced at $1.65, while ITGR trades at $118.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ITGR's P/E ratio is 54.90. In terms of profitability, COCH's ROE is +1.06%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, COCH is less volatile compared to ITGR. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs AXNX Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, AXNX has a market cap of 3.63B. Regarding current trading prices, COCH is priced at $1.65, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas AXNX's P/E ratio is -709.80. In terms of profitability, COCH's ROE is +1.06%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, COCH is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs PRCT Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, PRCT has a market cap of 3.19B. Regarding current trading prices, COCH is priced at $1.65, while PRCT trades at $57.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas PRCT's P/E ratio is -34.15. In terms of profitability, COCH's ROE is +1.06%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, COCH is less volatile compared to PRCT. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs LIVN Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, LIVN has a market cap of 2.35B. Regarding current trading prices, COCH is priced at $1.65, while LIVN trades at $43.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas LIVN's P/E ratio is -10.61. In terms of profitability, COCH's ROE is +1.06%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, COCH is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs NUVA Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, NUVA has a market cap of 2.08B. Regarding current trading prices, COCH is priced at $1.65, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas NUVA's P/E ratio is 75.00. In terms of profitability, COCH's ROE is +1.06%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, COCH is less volatile compared to NUVA. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs ATEC Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ATEC has a market cap of 1.82B. Regarding current trading prices, COCH is priced at $1.65, while ATEC trades at $12.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ATEC's P/E ratio is -10.95. In terms of profitability, COCH's ROE is +1.06%, compared to ATEC's ROE of -2.58%. Regarding short-term risk, COCH is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs UFPT Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, UFPT has a market cap of 1.80B. Regarding current trading prices, COCH is priced at $1.65, while UFPT trades at $233.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas UFPT's P/E ratio is 28.64. In terms of profitability, COCH's ROE is +1.06%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, COCH is less volatile compared to UFPT. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs CNMD Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, CNMD has a market cap of 1.73B. Regarding current trading prices, COCH is priced at $1.65, while CNMD trades at $56.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas CNMD's P/E ratio is 14.71. In terms of profitability, COCH's ROE is +1.06%, compared to CNMD's ROE of +0.13%. Regarding short-term risk, COCH is less volatile compared to CNMD. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs TNDM Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, TNDM has a market cap of 1.37B. Regarding current trading prices, COCH is priced at $1.65, while TNDM trades at $20.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas TNDM's P/E ratio is -7.40. In terms of profitability, COCH's ROE is +1.06%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, COCH is less volatile compared to TNDM. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs HSKA Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, HSKA has a market cap of 1.31B. Regarding current trading prices, COCH is priced at $1.65, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas HSKA's P/E ratio is -62.49. In terms of profitability, COCH's ROE is +1.06%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, COCH is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs AORT Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, AORT has a market cap of 1.21B. Regarding current trading prices, COCH is priced at $1.65, while AORT trades at $28.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas AORT's P/E ratio is -55.76. In terms of profitability, COCH's ROE is +1.06%, compared to AORT's ROE of -0.07%. Regarding short-term risk, COCH is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs AHCO Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, AHCO has a market cap of 1.21B. Regarding current trading prices, COCH is priced at $1.65, while AHCO trades at $8.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas AHCO's P/E ratio is 15.41. In terms of profitability, COCH's ROE is +1.06%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, COCH is less volatile compared to AHCO. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs SILK Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, SILK has a market cap of 1.12B. Regarding current trading prices, COCH is priced at $1.65, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas SILK's P/E ratio is -18.96. In terms of profitability, COCH's ROE is +1.06%, compared to SILK's ROE of -0.37%. Regarding short-term risk, COCH is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs FNA Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, FNA has a market cap of 1.10B. Regarding current trading prices, COCH is priced at $1.65, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas FNA's P/E ratio is -19.83. In terms of profitability, COCH's ROE is +1.06%, compared to FNA's ROE of -0.36%. Regarding short-term risk, COCH is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs ESTA Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ESTA has a market cap of 1.07B. Regarding current trading prices, COCH is priced at $1.65, while ESTA trades at $36.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ESTA's P/E ratio is -11.81. In terms of profitability, COCH's ROE is +1.06%, compared to ESTA's ROE of -2.10%. Regarding short-term risk, COCH is less volatile compared to ESTA. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs INMD Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, INMD has a market cap of 996.78M. Regarding current trading prices, COCH is priced at $1.65, while INMD trades at $14.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas INMD's P/E ratio is 6.43. In terms of profitability, COCH's ROE is +1.06%, compared to INMD's ROE of +0.25%. Regarding short-term risk, COCH is less volatile compared to INMD. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs IART Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, IART has a market cap of 983.84M. Regarding current trading prices, COCH is priced at $1.65, while IART trades at $12.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas IART's P/E ratio is -33.32. In terms of profitability, COCH's ROE is +1.06%, compared to IART's ROE of -0.03%. Regarding short-term risk, COCH is less volatile compared to IART. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs CSII Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, CSII has a market cap of 843.96M. Regarding current trading prices, COCH is priced at $1.65, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas CSII's P/E ratio is -20.83. In terms of profitability, COCH's ROE is +1.06%, compared to CSII's ROE of -0.14%. Regarding short-term risk, COCH is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs SIBN Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, SIBN has a market cap of 784.96M. Regarding current trading prices, COCH is priced at $1.65, while SIBN trades at $18.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas SIBN's P/E ratio is -29.24. In terms of profitability, COCH's ROE is +1.06%, compared to SIBN's ROE of -0.16%. Regarding short-term risk, COCH is less volatile compared to SIBN. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs CRY Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, CRY has a market cap of 725.15M. Regarding current trading prices, COCH is priced at $1.65, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas CRY's P/E ratio is 425.71. In terms of profitability, COCH's ROE is +1.06%, compared to CRY's ROE of -0.07%. Regarding short-term risk, COCH is less volatile compared to CRY. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs IRMD Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, IRMD has a market cap of 664.75M. Regarding current trading prices, COCH is priced at $1.65, while IRMD trades at $52.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas IRMD's P/E ratio is 33.73. In terms of profitability, COCH's ROE is +1.06%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, COCH is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs RXST Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, RXST has a market cap of 645.72M. Regarding current trading prices, COCH is priced at $1.65, while RXST trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas RXST's P/E ratio is -24.08. In terms of profitability, COCH's ROE is +1.06%, compared to RXST's ROE of -0.10%. Regarding short-term risk, COCH is less volatile compared to RXST. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs CBLL Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, CBLL has a market cap of 623.83M. Regarding current trading prices, COCH is priced at $1.65, while CBLL trades at $17.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas CBLL's P/E ratio is -13.81. In terms of profitability, COCH's ROE is +1.06%, compared to CBLL's ROE of -1.64%. Regarding short-term risk, COCH is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs NPCE Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, NPCE has a market cap of 585.45M. Regarding current trading prices, COCH is priced at $1.65, while NPCE trades at $17.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas NPCE's P/E ratio is -21.77. In terms of profitability, COCH's ROE is +1.06%, compared to NPCE's ROE of -1.40%. Regarding short-term risk, COCH is less volatile compared to NPCE. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs APEN Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, APEN has a market cap of 579.72M. Regarding current trading prices, COCH is priced at $1.65, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas APEN's P/E ratio is -9.43. In terms of profitability, COCH's ROE is +1.06%, compared to APEN's ROE of -0.85%. Regarding short-term risk, COCH is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs AVNS Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, AVNS has a market cap of 576.66M. Regarding current trading prices, COCH is priced at $1.65, while AVNS trades at $12.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas AVNS's P/E ratio is -1.51. In terms of profitability, COCH's ROE is +1.06%, compared to AVNS's ROE of -0.37%. Regarding short-term risk, COCH is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs BFLY Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, BFLY has a market cap of 527.96M. Regarding current trading prices, COCH is priced at $1.65, while BFLY trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas BFLY's P/E ratio is -7.12. In terms of profitability, COCH's ROE is +1.06%, compared to BFLY's ROE of -0.33%. Regarding short-term risk, COCH is less volatile compared to BFLY. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs KIDS Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, KIDS has a market cap of 523.86M. Regarding current trading prices, COCH is priced at $1.65, while KIDS trades at $21.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas KIDS's P/E ratio is -12.02. In terms of profitability, COCH's ROE is +1.06%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, COCH is less volatile compared to KIDS. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs SMLR Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, SMLR has a market cap of 501.04M. Regarding current trading prices, COCH is priced at $1.65, while SMLR trades at $44.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas SMLR's P/E ratio is -18.80. In terms of profitability, COCH's ROE is +1.06%, compared to SMLR's ROE of -0.21%. Regarding short-term risk, COCH is less volatile compared to SMLR. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs AXGN Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, AXGN has a market cap of 498.25M. Regarding current trading prices, COCH is priced at $1.65, while AXGN trades at $10.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas AXGN's P/E ratio is -68.37. In terms of profitability, COCH's ROE is +1.06%, compared to AXGN's ROE of -0.07%. Regarding short-term risk, COCH is less volatile compared to AXGN. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs BFLY-WT Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, BFLY-WT has a market cap of 491.41M. Regarding current trading prices, COCH is priced at $1.65, while BFLY-WT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, COCH's ROE is +1.06%, compared to BFLY-WT's ROE of -0.33%. Regarding short-term risk, COCH is less volatile compared to BFLY-WT. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs OFIX Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, OFIX has a market cap of 440.00M. Regarding current trading prices, COCH is priced at $1.65, while OFIX trades at $11.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas OFIX's P/E ratio is -3.04. In terms of profitability, COCH's ROE is +1.06%, compared to OFIX's ROE of -0.28%. Regarding short-term risk, COCH is less volatile compared to OFIX. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs BVS Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, BVS has a market cap of 431.99M. Regarding current trading prices, COCH is priced at $1.65, while BVS trades at $6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas BVS's P/E ratio is -13.56. In terms of profitability, COCH's ROE is +1.06%, compared to BVS's ROE of -0.21%. Regarding short-term risk, COCH is less volatile compared to BVS. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs SRDX Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, SRDX has a market cap of 416.97M. Regarding current trading prices, COCH is priced at $1.65, while SRDX trades at $29.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas SRDX's P/E ratio is -20.83. In terms of profitability, COCH's ROE is +1.06%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, COCH is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs SENS Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, SENS has a market cap of 391.48M. Regarding current trading prices, COCH is priced at $1.65, while SENS trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas SENS's P/E ratio is -4.72. In terms of profitability, COCH's ROE is +1.06%, compared to SENS's ROE of -7.46%. Regarding short-term risk, COCH is less volatile compared to SENS. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs TMCI Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, TMCI has a market cap of 383.72M. Regarding current trading prices, COCH is priced at $1.65, while TMCI trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas TMCI's P/E ratio is -7.18. In terms of profitability, COCH's ROE is +1.06%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, COCH is less volatile compared to TMCI. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs CLPT Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, CLPT has a market cap of 341.44M. Regarding current trading prices, COCH is priced at $1.65, while CLPT trades at $12.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas CLPT's P/E ratio is -15.89. In terms of profitability, COCH's ROE is +1.06%, compared to CLPT's ROE of -0.78%. Regarding short-term risk, COCH is less volatile compared to CLPT. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs NNOX Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, NNOX has a market cap of 334.11M. Regarding current trading prices, COCH is priced at $1.65, while NNOX trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas NNOX's P/E ratio is -5.76. In terms of profitability, COCH's ROE is +1.06%, compared to NNOX's ROE of -0.30%. Regarding short-term risk, COCH is less volatile compared to NNOX. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs OM Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, OM has a market cap of 327.33M. Regarding current trading prices, COCH is priced at $1.65, while OM trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas OM's P/E ratio is -0.64. In terms of profitability, COCH's ROE is +1.06%, compared to OM's ROE of -1.45%. Regarding short-term risk, COCH is less volatile compared to OM. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs VREX Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, VREX has a market cap of 320.80M. Regarding current trading prices, COCH is priced at $1.65, while VREX trades at $7.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas VREX's P/E ratio is -7.50. In terms of profitability, COCH's ROE is +1.06%, compared to VREX's ROE of -0.08%. Regarding short-term risk, COCH is less volatile compared to VREX. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs CTKB Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, CTKB has a market cap of 310.31M. Regarding current trading prices, COCH is priced at $1.65, while CTKB trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas CTKB's P/E ratio is -27.22. In terms of profitability, COCH's ROE is +1.06%, compared to CTKB's ROE of -0.03%. Regarding short-term risk, COCH is less volatile compared to CTKB. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs PACB Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, PACB has a market cap of 282.53M. Regarding current trading prices, COCH is priced at $1.65, while PACB trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas PACB's P/E ratio is -0.34. In terms of profitability, COCH's ROE is +1.06%, compared to PACB's ROE of -1.70%. Regarding short-term risk, COCH is less volatile compared to PACB. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs VMD Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, VMD has a market cap of 257.70M. Regarding current trading prices, COCH is priced at $1.65, while VMD trades at $6.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas VMD's P/E ratio is 21.73. In terms of profitability, COCH's ROE is +1.06%, compared to VMD's ROE of +0.10%. Regarding short-term risk, COCH is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs MXCT Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, MXCT has a market cap of 239.22M. Regarding current trading prices, COCH is priced at $1.65, while MXCT trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas MXCT's P/E ratio is -5.62. In terms of profitability, COCH's ROE is +1.06%, compared to MXCT's ROE of -0.20%. Regarding short-term risk, COCH is less volatile compared to MXCT. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs CERS Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, CERS has a market cap of 238.95M. Regarding current trading prices, COCH is priced at $1.65, while CERS trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas CERS's P/E ratio is -12.50. In terms of profitability, COCH's ROE is +1.06%, compared to CERS's ROE of -0.35%. Regarding short-term risk, COCH is less volatile compared to CERS. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs ZIMV Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ZIMV has a market cap of 233.14M. Regarding current trading prices, COCH is priced at $1.65, while ZIMV trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ZIMV's P/E ratio is -9.28. In terms of profitability, COCH's ROE is +1.06%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, COCH is less volatile compared to ZIMV. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs TCMD Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, TCMD has a market cap of 228.07M. Regarding current trading prices, COCH is priced at $1.65, while TCMD trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas TCMD's P/E ratio is 14.86. In terms of profitability, COCH's ROE is +1.06%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, COCH is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs NVRO Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, NVRO has a market cap of 224.09M. Regarding current trading prices, COCH is priced at $1.65, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas NVRO's P/E ratio is -1.91. In terms of profitability, COCH's ROE is +1.06%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, COCH is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs EYES Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, EYES has a market cap of 210.05M. Regarding current trading prices, COCH is priced at $1.65, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas EYES's P/E ratio is N/A. In terms of profitability, COCH's ROE is +1.06%, compared to EYES's ROE of -0.26%. Regarding short-term risk, COCH is less volatile compared to EYES. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs TLSI Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, TLSI has a market cap of 202.44M. Regarding current trading prices, COCH is priced at $1.65, while TLSI trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas TLSI's P/E ratio is -4.86. In terms of profitability, COCH's ROE is +1.06%, compared to TLSI's ROE of +1.07%. Regarding short-term risk, COCH is less volatile compared to TLSI. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs BWAY Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, BWAY has a market cap of 196.83M. Regarding current trading prices, COCH is priced at $1.65, while BWAY trades at $10.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas BWAY's P/E ratio is 47.41. In terms of profitability, COCH's ROE is +1.06%, compared to BWAY's ROE of +0.06%. Regarding short-term risk, COCH is less volatile compared to BWAY. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs QTRX Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, QTRX has a market cap of 187.55M. Regarding current trading prices, COCH is priced at $1.65, while QTRX trades at $4.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas QTRX's P/E ratio is -3.90. In terms of profitability, COCH's ROE is +1.06%, compared to QTRX's ROE of -0.15%. Regarding short-term risk, COCH is less volatile compared to QTRX. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs CATX Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, CATX has a market cap of 187.06M. Regarding current trading prices, COCH is priced at $1.65, while CATX trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas CATX's P/E ratio is -2.05. In terms of profitability, COCH's ROE is +1.06%, compared to CATX's ROE of -0.27%. Regarding short-term risk, COCH is less volatile compared to CATX. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs INGN Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, INGN has a market cap of 181.49M. Regarding current trading prices, COCH is priced at $1.65, while INGN trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas INGN's P/E ratio is -5.87. In terms of profitability, COCH's ROE is +1.06%, compared to INGN's ROE of -0.15%. Regarding short-term risk, COCH is less volatile compared to INGN. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs BDMD Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, BDMD has a market cap of 179.36M. Regarding current trading prices, COCH is priced at $1.65, while BDMD trades at $5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas BDMD's P/E ratio is 10.24. In terms of profitability, COCH's ROE is +1.06%, compared to BDMD's ROE of +0.12%. Regarding short-term risk, COCH is more volatile compared to BDMD. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs CVRX Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, CVRX has a market cap of 173.38M. Regarding current trading prices, COCH is priced at $1.65, while CVRX trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas CVRX's P/E ratio is -3.11. In terms of profitability, COCH's ROE is +1.06%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, COCH is less volatile compared to CVRX. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs MASS Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, MASS has a market cap of 169.98M. Regarding current trading prices, COCH is priced at $1.65, while MASS trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas MASS's P/E ratio is -2.14. In terms of profitability, COCH's ROE is +1.06%, compared to MASS's ROE of -0.13%. Regarding short-term risk, COCH is less volatile compared to MASS. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs SGHT Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, SGHT has a market cap of 169.58M. Regarding current trading prices, COCH is priced at $1.65, while SGHT trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas SGHT's P/E ratio is -3.35. In terms of profitability, COCH's ROE is +1.06%, compared to SGHT's ROE of -0.55%. Regarding short-term risk, COCH is less volatile compared to SGHT. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs ELMD Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ELMD has a market cap of 169.57M. Regarding current trading prices, COCH is priced at $1.65, while ELMD trades at $20.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ELMD's P/E ratio is 25.59. In terms of profitability, COCH's ROE is +1.06%, compared to ELMD's ROE of +0.17%. Regarding short-term risk, COCH is less volatile compared to ELMD. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs RCEL Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, RCEL has a market cap of 169.18M. Regarding current trading prices, COCH is priced at $1.65, while RCEL trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas RCEL's P/E ratio is -2.92. In terms of profitability, COCH's ROE is +1.06%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, COCH is less volatile compared to RCEL. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs ANIK Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ANIK has a market cap of 168.80M. Regarding current trading prices, COCH is priced at $1.65, while ANIK trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ANIK's P/E ratio is -15.69. In terms of profitability, COCH's ROE is +1.06%, compared to ANIK's ROE of -0.33%. Regarding short-term risk, COCH is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs LNSR Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, LNSR has a market cap of 166.43M. Regarding current trading prices, COCH is priced at $1.65, while LNSR trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas LNSR's P/E ratio is -2.88. In terms of profitability, COCH's ROE is +1.06%, compared to LNSR's ROE of -5.28%. Regarding short-term risk, COCH is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs PROF Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, PROF has a market cap of 154.17M. Regarding current trading prices, COCH is priced at $1.65, while PROF trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas PROF's P/E ratio is -4.24. In terms of profitability, COCH's ROE is +1.06%, compared to PROF's ROE of -0.70%. Regarding short-term risk, COCH is less volatile compared to PROF. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs LUCD Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, LUCD has a market cap of 143.89M. Regarding current trading prices, COCH is priced at $1.65, while LUCD trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas LUCD's P/E ratio is -1.14. In terms of profitability, COCH's ROE is +1.06%, compared to LUCD's ROE of +26.96%. Regarding short-term risk, COCH is less volatile compared to LUCD. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs RPID Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, RPID has a market cap of 138.07M. Regarding current trading prices, COCH is priced at $1.65, while RPID trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas RPID's P/E ratio is -3.06. In terms of profitability, COCH's ROE is +1.06%, compared to RPID's ROE of -0.56%. Regarding short-term risk, COCH is less volatile compared to RPID. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs LUNG Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, LUNG has a market cap of 125.60M. Regarding current trading prices, COCH is priced at $1.65, while LUNG trades at $3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas LUNG's P/E ratio is -2.17. In terms of profitability, COCH's ROE is +1.06%, compared to LUNG's ROE of -0.64%. Regarding short-term risk, COCH is less volatile compared to LUNG. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs AVR Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, AVR has a market cap of 116.09M. Regarding current trading prices, COCH is priced at $1.65, while AVR trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas AVR's P/E ratio is -1.63. In terms of profitability, COCH's ROE is +1.06%, compared to AVR's ROE of -2.92%. Regarding short-term risk, COCH is less volatile compared to AVR. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs BSGM Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, BSGM has a market cap of 116.00M. Regarding current trading prices, COCH is priced at $1.65, while BSGM trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas BSGM's P/E ratio is -8.02. In terms of profitability, COCH's ROE is +1.06%, compared to BSGM's ROE of +7.10%. Regarding short-term risk, COCH is less volatile compared to BSGM. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs MYO Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, MYO has a market cap of 114.59M. Regarding current trading prices, COCH is priced at $1.65, while MYO trades at $3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas MYO's P/E ratio is -22.75. In terms of profitability, COCH's ROE is +1.06%, compared to MYO's ROE of -0.36%. Regarding short-term risk, COCH is less volatile compared to MYO. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs ICAD Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ICAD has a market cap of 102.65M. Regarding current trading prices, COCH is priced at $1.65, while ICAD trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ICAD's P/E ratio is -19.68. In terms of profitability, COCH's ROE is +1.06%, compared to ICAD's ROE of -0.17%. Regarding short-term risk, COCH is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs XTNT Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, XTNT has a market cap of 98.92M. Regarding current trading prices, COCH is priced at $1.65, while XTNT trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas XTNT's P/E ratio is -7.89. In terms of profitability, COCH's ROE is +1.06%, compared to XTNT's ROE of -0.27%. Regarding short-term risk, COCH is less volatile compared to XTNT. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs HJLI Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, HJLI has a market cap of 98.32M. Regarding current trading prices, COCH is priced at $1.65, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas HJLI's P/E ratio is N/A. In terms of profitability, COCH's ROE is +1.06%, compared to HJLI's ROE of -0.51%. Regarding short-term risk, COCH is less volatile compared to HJLI. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.
COCH vs ASXC Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, ASXC has a market cap of 94.92M. Regarding current trading prices, COCH is priced at $1.65, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas ASXC's P/E ratio is -1.12. In terms of profitability, COCH's ROE is +1.06%, compared to ASXC's ROE of -4.07%. Regarding short-term risk, COCH is more volatile compared to ASXC. This indicates potentially higher risk in terms of short-term price fluctuations for COCH.
COCH vs MGRM Comparison
COCH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, COCH stands at 35.19M. In comparison, MGRM has a market cap of 93.50M. Regarding current trading prices, COCH is priced at $1.65, while MGRM trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
COCH currently has a P/E ratio of -1.20, whereas MGRM's P/E ratio is -5.24. In terms of profitability, COCH's ROE is +1.06%, compared to MGRM's ROE of -1.26%. Regarding short-term risk, COCH is less volatile compared to MGRM. This indicates potentially lower risk in terms of short-term price fluctuations for COCH.